EU-U.S. trade talks: milestone reached in mutual recognition on pharmaceuticals
The European Union and the United States yesterday delivered on a significant element of the Joint Statement agreed by Presidents Juncker and Trump in July 2018. The positive transatlantic trade agenda established in the Joint Statement includes a commitment from both sides to reduce barriers and increase trade in a range of sectors, including pharmaceuticals.
The recognition yesterday by the U.S. Food and Drug Administration (FDA) of Slovakia, the last outstanding EU Member State, marks the full implementation of the EU-U.S. Mutual Recognition Agreement (MRA) for inspections of manufacturing sites for human medicines in their respective territories. This can make it faster and less costly for both sides to bring medicines to the market.
Commissioner Vytenis Andriukaitis, in charge of Health and Food Safety yesterday said:
"The completion of the Mutual Recognition Agreement is not only a step forward in the trade relations between the EU and the U.S., but it will also ensure high quality medicines for the benefit of patients. It means that, on both sides of the Atlantic, the authorities in charge of medicines can now rely on inspections results to replace their own inspections. Today, the U.S. Food and Drug Administration has completed the capability assessments of the 28 EU competent authorities, the result of five years of close transatlantic cooperation”.
This Mutual Recognition Agreement is underpinned by robust evidence that the EU and the U.S. have comparable procedures to carry out good manufacturing practice inspections for human medicines.
Together, Europe and the United States account for more than 80% of global sales of new medicines. As a result of the full implementation of this agreement, both the industry and public authorities on both sides will be able to free resources that could be used to inspect facilities in other large producing countries.
The pharmaceutical industry is a strategic sector in which EU-U.S. regulatory cooperation is much more advanced than in most other sectors. Since May 2014, teams from the European Commission, EU national competent authorities, the European Medicines Agency (EMA) and the U.S. Food and Drug Administration have been auditing and assessing the respective supervisory systems. The U.S. Food and Drug Administration has now assessed positively all national competent authorities of the EU.
From now on, the batch testing waiver will also start to apply. This means that the qualified persons in the EU pharmaceutical company will be relieved of their task for carrying out the quality controls when carried out already in the United States.
The Mutual Recognition Agreement implementation work will continue with view to expanding the operational scope to veterinary medicines, human vaccines and plasma derived medicinal products.
In 1998, the EU and the U.S. signed a broad Mutual Recognition Agreement, which included a Pharmaceutical Annex providing for anticipated and limited reliance on each other's Good Manufacturing Practices (GMP) inspections.
2017 marked the entry into operation of the agreement between the EU and the U.S. to recognise inspections of manufacturing sites for human medicines conducted in their respective territories. This agreement strengthens reliance upon each other's inspection expertise and resources. Initially it applied between the U.S. Food and Drug Administration and those EU Member States that the U.S. Food and Drug Administration had assessed. This has been gradually extended to all EU countries and now the regulatory authorities in all 28 EU Member States were recognised by the U.S. Food and Drug Administration. Meanwhile, the EU made the same determination about U.S. Food and Drug Administration in June 2017.
Latest News from
Ebola: EU announces new funds to strengthen preparedness in Burundi22/08/2019 12:25:00
The Ebola virus disease outbreak in the Democratic Republic of Congo continues to spread in the east of the country with a high risk of a spill-over into the neighbouring countries. The European Union is stepping up its assistance to Burundi with €465,000 to further strengthen Ebola preparedness measures by authorities and aid organisations in the country.
ECB shuts down compromised BIRD website16/08/2019 10:20:00
The European Central Bank (ECB) said on Thursday that unauthorised parties had breached the security measures protecting its Banks’ Integrated Reporting Dictionary (BIRD) website, which is hosted by an external provider. As a result, it was possible that the contact data (but not the passwords) of 481 subscribers to the BIRD newsletter may have been captured.
rescEU assets mobilised to help Greece fight devastating forest fires15/08/2019 10:25:00
Following a request for assistance from Greece on 13 August 2019, rescEU assets have been mobilised to tackle forest fires ravaging several areas of Greece.
EU mobilises €9m to tackle the food crisis in Haiti14/08/2019 10:20:00
The European Union has released €9m in humanitarian aid in response to the deteriorating food & nutrition situation in Haiti. The humanitarian aid will cover the basic food & nutritional needs of more than 130,000 people living in the worst affected areas.
Asylum applications in the EU+ up by 10 % in the first half of 2019 from the same period in 201813/08/2019 11:10:00
Preliminary analyses reveal that in the first half of 2019 some 337 200 applications for asylum were lodged in the EU+, a 10 % increase from the same period a year earlier. In contrast to this upward trend, in June 2019 applications fell to the lowest level of the year, but there were fewer working days.
EC provides 20 cities with funding for innovative security, digital, environmental and inclusion projects07/08/2019 15:20:00
The European Regional Development Fund (ERDF) will finance 20 urban projects with €82m. These projects were put forward by cities under the 4th call for proposals of the Urban Innovative Actions which is implemented by French region Hauts-de-France.
Public consultation: chlorinated paraffins in food and feed07/08/2019 13:25:00
EFSA is seeking feedback from interested parties on its scientific opinion about the risks to human and animal health related to the presence of chlorinated paraffins in food and feed.
The EU and the United States sign an agreement on imports of hormone-free beef06/08/2019 13:25:00
The EU and the United States have signed an agreement reviewing the functioning of an existing quota to import hormone-free beef into the EU.
State aid: France to recover €8.5m of illegal aid to Ryanair at Montpellier airport05/08/2019 13:25:00
The EC has found that the marketing agreements concluded between the local Association for the Promotion of Touristic and Economic Flows (APFTE) and Ryanair at the airport of Montpellier are illegal under EU State aid rules. Ryanair now has to return €8.5m of illegal State aid.